Contrastingly, continuous exposure to PTH, as observed in hyperparathyroidism, is catabolic to bone, increasing osteoclastogenesis through upregulation of RANKL and inhibition of osteoprotegerin expression [22]. The gene discussed is TNFRSF11B; the disease is hyperparathyroidism.